The in vitro fertilization (IVF) market is anticipated to expand at a CAGR of 10.60% over the forecast period, from US$20.046 billion in 2020 to a total market value of US$40.577 billion by 2027.
A sophisticated set of techniques known as in vitro fertilization (IVF) is used to cure genetic or reproductive issues and aid in child conception. Patients with blocked or damaged fallopian tubes, male factor infertility, women with ovulation disorders, premature ovarian failure, uterine fibroids, excised fallopian tubes, and unexplained infertility are among the infertility conditions that can be treated with IVF. The increase may be attributable to the increased rates of male and female infertility brought on by lifestyle changes. Growing public understanding and acceptance of infertility treatment will encourage the use of in vitro fertilization (IVF) methods, which will accelerate the development of the in vitro fertilization (IVF) market.
However, the main factor limiting the potential market for in vitro fertilization (IVF) is the cost of the treatments, which is well-known around the world.
The Increasing Number of Median age of first-time mothers is driving the market growth
Because more women are choosing careers over family planning and later marriages than in the past, the median age of first-time mothers has increased significantly as a result of the expanding human population. The effective use of contraceptives has also significantly influenced the median age of first-time mothers, and this is anticipated to significantly fuel the expansion of the in vitro fertilization (IVF) market.
By body part, the In-Vitro Fertilization Market is segmented as Fertility Clinics Hospitals & Research Centers. The Clinical research centers are anticipated to have the fastest growth owing to the majority of research on fertility problems and their possible treatment.
Geographically, the In-Vitro Fertilization Market is segmented as North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The greatest market share corresponds to the Asia-Pacific region, which has a huge population base, rising IVF treatment awareness, low IVF treatment prices, and an increase in the population of infertile people.
|Market Size Value in 2020||US$20.046 billion|
|Market Size Value in 2027||US$40.577 billion|
|Growth Rate||CAGR of 10.60% from 2020 to 2027|
|Forecast Unit (Value)||USD Billion|
|Segments Covered||Cycle Type, End-User, And Geography|
|Regions Covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies Covered||Cooper Surgical, Vitrolife AB, Thermo Fisher Scientific Inc., Cook, FUJIFILM Irvine Scientific, Nikon Instruments Inc., Merck KGaA, Genea Limited, IVFtech ApS, Hamilton Thorne, Inc.|
|Customization Scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What will be the In vitro fertilization (IVF) market size by 2027?
A1. The in vitro fertilization (IVF) market is anticipated to reach a total market size of US$40.577 billion by 2027.
Q2. What is the size of the global IVF market?
A2. In Vitro Fertilization Market was valued at US$20.046 billion in 2020.
Q3. What are the growth prospects for the In vitro fertilization market?
A3. The global in vitro fertilization (IVF) market is anticipated to expand at a CAGR of 10.60% during the forecast period.
Q4. How is the global IVF market segmented?
A4. The global IVF market has been segmented by cycle type, end-user, and geography.
Q5. What factors are anticipated to drive the In vitro fertilization (IVF) market growth?
A5. The global IVF services market growth may be attributed to the rising male and female infertility rates due to the changing lifestyle.
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. GLOBAL IN-VITRO FERTILIZATION (IVF) MARKET ANALYSIS, BY CYCLE TYPE
5.2. Fresh IVF Cycle
5.3. Thawed IVF Cycle
5.4. Donor Egg IVF Cycles
6. GLOBAL IN-VITRO FERTILIZATION (IVF) MARKET ANALYSIS, BY END-USER
6.2. Fertility clinics
6.3. Hospitals and research centers
7. GLOBAL IN-VITRO FERTILIZATION (IVF) MARKET ANALYSIS, BY GEOGRAPHY
7.2. North America
7.3. South America
7.4.3. United Kingdom
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.6. Asia Pacific
7.6.4. South Korea
8. COMPETITIVE INTELLIGENCE
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. COMPANY PROFILES
9.1. Cooper Surgical
9.2. Vitrolife AB
9.3. Thermo Fisher Scientific Inc.
9.5. FUJIFILM Irvine Scientific
9.6. Nikon Instruments Inc.
9.7. Merck KGaA
9.8. Genea Limited
9.9. IVFtech ApS
9.10. Hamilton Thorne, Inc.
Thermo Fisher Scientific Inc.
FUJIFILM Irvine Scientific
Nikon Instruments Inc.
Hamilton Thorne, Inc.
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.